bioRxivBiochemistryPreprint
Direct binding of TDP-43 and Tau drives their co-condensation, but suppresses Tau fibril formation and seeding
Francesca SimonettiiD, Weijia ZhongiD, Saskia HutteniD, Federico UlianaiD, Martina SchiffereriD, Ali RezaeiiD, Lisa Marie RamireziD, Janine HochmairiD, Rithika SankariD, Anusha B. GopalaniD, Fridolin KielischiD, Henrick RiemenschneideriD, Viktoria RufiD, Mikael SimonsiD, Markus ZweckstetteriD, Susanne WegmanniD, Tammaryn LashleyiD, Magdalini PolymenidouiD, Dieter EdbaueriD, Dorothee DormanniD
Abstract
Neuronal Tau aggregates are a hallmark of Alzheimers disease (AD), but more than half of the patients exhibit additional TDP-43 inclusions and some have co-aggregates of both proteins. The presence of Tau/TDP-43 co-pathology is associated with increased disease severity, although the causal relationship remains unclear. Here we demonstrate that Tau and TDP-43 mutually promote each others condensation through direct interaction in vitro, forming irregularly shaped or multiphasic co-condensates with lower TDP-43 mobility, but higher Tau dynamics. While Tau promotes TDP-43 aggregation in vitro, TDP-43 suppresses formation of Tau fibrils and instead causes formation of oligomeric Tau and Tau/TDP-43 species. These co-assemblies hinder Tau seeding in a biosensor assay specific for proteopathic Tau seeds. Consistent with this data, SarkoSpin extracts from AD brains with Tau/TDP-43 co-pathology exhibit reduced Tau seeding compared to Tau-only AD brains. In contrast, patient-derived extracts from AD brains with Tau/TDP-43 co-pathology are highly potent in seeding TDP-43 neoaggregates in a TDP-43 reporter cell line. Our results suggest that direct interaction of TDP-43 and Tau may suppress Tau pathology, while promoting TDP-43 pathology. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=133 SRC="FIGDIR/small/662960v1_ufig1.gif" ALT="Figure 1"> View larger version (23K): org.highwire.dtl.DTLVardef@1ed5dfaorg.highwire.dtl.DTLVardef@b4ef07org.highwire.dtl.DTLVardef@b8dbe8org.highwire.dtl.DTLVardef@6d9b49_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- research focus: cell signaling & trafficking
- research focus: differential expression
- research focus: protein folding & dynamics
- approach: experimental assay
- approach: wet-lab / biochemical assay
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Tauopathy primes co-filament assembly and dysfunction of TDP-43
Meghraj Singh Baghel, Grace D. Burns, … Philip C. Wong·bioRxiv·May 14, 2026
- Prion-like C-terminal domain of TDP-43 and α-Synuclein interact synergistically to generate neurotoxic hybrid fibrils
S. Dhakal, C. E. Wyant, … V. Rangachari·bioRxiv·Dec 12, 2020
- Alpha-Synuclein co-pathology in Alzheimer's Disease drives tau accumulation
Felix L. Struebing, Xiaoxuan Song, … Jochen Wolfgang Herms·bioRxiv·Jan 24, 2025
- Nanomolar interactions of alpha-synuclein fibrils to tau determined by FCS
J. Ramirez, E. A. E. Brackhahn, … E. Rhoades·bioRxiv·Apr 13, 2023
- Zinc Differentially Modulates Tau Aggregation, Fibril Morphology, and Prion-like Seeding in a Construct-Dependent Manner
Emma L. Poirier, Alyssa Stainton, … Jennifer N. Rauch·bioRxiv·Jul 2, 2026
- An autoinhibitory regulatory switch governs heterotypic phase separation and liquid-to-solid phase transition of TDP-43 and tau into cytotoxic amyloids
Anuja Walimbe, Snehasis Sarkar, … Samrat Mukhopadhyay·bioRxiv·May 27, 2026